tiprankstipranks
Trending News
More News >
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market

Harmony Biosciences Holdings (HRMY) Ratios

Compare
293 Followers

Harmony Biosciences Holdings Ratios

HRMY's free cash flow for Q1 2025 was $0.83. For the 2025 fiscal year, HRMY's free cash flow was decreased by $ and operating cash flow was $0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.67 2.75 5.07 5.29 1.95
Quick Ratio
3.63 2.72 5.02 5.21 1.93
Cash Ratio
2.79 1.90 3.09 4.36 1.70
Solvency Ratio
0.51 0.44 0.76 0.22 -0.13
Operating Cash Flow Ratio
1.27 1.34 1.83 1.83 -0.02
Short-Term Operating Cash Flow Coverage
12.72 14.63 72.23 49.28 0.00
Net Current Asset Value
$ 307.68M$ 106.61M$ 129.25M$ 37.50M$ -67.00M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.24 0.28 0.44 0.45
Debt-to-Equity Ratio
0.02 0.41 0.48 1.03 2.00
Debt-to-Capital Ratio
0.02 0.29 0.32 0.51 0.67
Long-Term Debt-to-Capital Ratio
0.00 0.28 0.32 0.50 0.67
Financial Leverage Ratio
1.46 1.74 1.67 2.32 4.39
Debt Service Coverage Ratio
7.56 4.57 12.47 3.99 -0.47
Interest Coverage Ratio
21.37 8.08 7.67 2.87 0.13
Debt to Market Cap
<0.01 0.10 0.06 0.08 0.09
Interest Debt Per Share
0.46 3.65 3.50 3.75 3.91
Net Debt to EBITDA
-2.12 -0.53 -0.36 -0.40 -22.72
Profitability Margins
Gross Profit Margin
77.54%79.17%80.93%81.82%82.64%
EBIT Margin
27.06%33.87%27.45%20.17%10.63%
EBITDA Margin
29.87%38.06%32.79%34.82%0.95%
Operating Profit Margin
26.18%32.99%27.45%22.49%2.30%
Pretax Profit Margin
26.47%29.79%23.91%12.25%-23.13%
Net Profit Margin
20.50%22.14%41.44%11.33%-32.46%
Continuous Operations Profit Margin
20.50%22.14%41.44%11.33%-23.13%
Net Income Per EBT
77.45%74.31%173.35%92.44%140.36%
EBT Per EBIT
101.11%90.30%87.10%54.48%-1004.46%
Return on Assets (ROA)
14.47%15.88%26.93%7.98%-12.14%
Return on Equity (ROE)
24.29%27.59%45.05%18.55%-53.36%
Return on Capital Employed (ROCE)
22.15%29.65%20.20%18.10%1.26%
Return on Invested Capital (ROIC)
19.38%21.53%34.90%16.64%1.76%
Return on Tangible Assets
16.11%19.11%35.38%11.95%-19.59%
Earnings Yield
7.97%6.71%5.57%1.41%-2.52%
Efficiency Ratios
Receivables Turnover
7.03 7.85 8.00 8.77 7.20
Payables Turnover
0.00 6.84 22.05 55.46 10.85
Inventory Turnover
26.20 22.61 19.43 12.53 7.26
Fixed Asset Turnover
540.53 1.57K 764.14 372.49 170.30
Asset Turnover
0.71 0.72 0.65 0.70 0.37
Working Capital Turnover Ratio
1.71 1.91 1.59 1.70 2.28
Cash Conversion Cycle
65.86 9.26 47.87 64.19 67.34
Days of Sales Outstanding
51.93 46.49 45.63 41.64 50.67
Days of Inventory Outstanding
13.93 16.15 18.79 29.14 50.31
Days of Payables Outstanding
0.00 53.38 16.55 6.58 33.63
Operating Cycle
65.86 62.64 64.42 70.78 100.98
Cash Flow Ratios
Operating Cash Flow Per Share
3.89 3.69 2.44 1.71 -0.05
Free Cash Flow Per Share
3.86 3.68 1.76 -0.03 -0.09
CapEx Per Share
0.02 <0.01 0.68 1.74 0.04
Free Cash Flow to Operating Cash Flow
0.99 1.00 0.72 -0.02 1.67
Dividend Paid and CapEx Coverage Ratio
174.50 703.16 3.60 0.98 -1.49
Capital Expenditure Coverage Ratio
174.50 703.16 3.60 0.98 -1.49
Operating Cash Flow Coverage Ratio
12.72 1.13 0.75 0.51 -0.02
Operating Cash Flow to Sales Ratio
0.30 0.38 0.33 0.32 -0.02
Free Cash Flow Yield
11.54%11.40%3.20%-0.07%-0.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.55 14.91 17.97 70.91 -39.66
Price-to-Sales (P/S) Ratio
2.58 3.30 7.45 8.03 12.87
Price-to-Book (P/B) Ratio
2.66 4.11 8.09 13.15 21.16
Price-to-Free Cash Flow (P/FCF) Ratio
8.67 8.77 31.26 -1.41K -412.39
Price-to-Operating Cash Flow Ratio
8.61 8.76 22.57 24.89 -688.98
Price-to-Earnings Growth (PEG) Ratio
2.92 -0.51 0.04 -0.43 0.63
Price-to-Fair Value
2.66 4.11 8.09 13.15 21.16
Enterprise Value Multiple
6.51 8.14 22.35 22.66 1.34K
Enterprise Value
EV to EBITDA
6.51 8.14 22.35 22.66 1.34K
EV to Sales
1.94 3.10 7.33 7.89 12.66
EV to Free Cash Flow
6.54 8.23 30.76 -1.38K -405.50
EV to Operating Cash Flow
6.50 8.22 22.21 24.46 -677.46
Tangible Book Value Per Share
10.70 5.55 4.09 0.74 -1.15
Shareholders’ Equity Per Share
12.57 7.85 6.81 3.24 1.71
Tax and Other Ratios
Effective Tax Rate
0.11 0.26 -0.73 0.08 -0.40
Revenue Per Share
13.00 9.79 7.40 5.31 2.81
Net Income Per Share
2.66 2.17 3.07 0.60 -0.91
Tax Burden
0.77 0.74 1.73 0.92 1.40
Interest Burden
0.98 0.88 0.87 0.61 -2.17
Research & Development to Revenue
0.21 0.13 0.16 0.10 0.12
SG&A to Revenue
0.16 0.16 0.19 0.21 0.25
Stock-Based Compensation to Revenue
0.06 0.05 0.06 0.05 0.03
Income Quality
1.46 1.70 0.80 2.85 0.08
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis